Short Interest in AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Rises By 321.3%

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 7,848 shares, a growth of 321.3% from the December 15th total of 1,863 shares. Based on an average trading volume of 1,541,052 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 1,541,052 shares, the short-interest ratio is presently 0.0 days.

AXIM Biotechnologies Trading Down 5.7%

Shares of AXIM stock opened at $0.01 on Tuesday. AXIM Biotechnologies has a 12 month low of $0.00 and a 12 month high of $0.03. The stock has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01.

About AXIM Biotechnologies

AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.

The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.